Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Patterson Companies, Inc.    PDCO

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

On July17, 2017, Neogen Corporation (the “Registrant”) named John Adent to serve as Chief Executive Officer of the Registrant, replacing James L. Herbert, who remains Executive Chairman of the Board of Directors.

Mr.Adent, age 49, served as the Chief Executive Officer of Patterson Animal Health, a subsidiary of Patterson Companies, Inc., a supplier of products to the animal health market, until July1, 2017. Prior to joining Patterson Animal Health, he served as President and Chief Executive Officer of Animal Health International, Inc. from 2004 through Patterson Companies, Inc.’s acquisition of Animal Health International, Inc. in 2015.

Mr.Adent will receive an annual base salary of $450,000 and will be eligible for bonuses of up to $450,000 per annum, based on achievement of agreed upon objectives. He was awarded an option to purchase 75,000 shares of the Registrant’s common stock according to the terms of the Registrant’s approved stock option plan on his date of hire at an exercise price equal to the closing price of the stock on that date. In addition to these benefits, Mr.Adent is eligible to receive benefits offered to other executive officers of the Registrant. If the Company dismisses Mr.Adent without cause during the first 12 months of his employment, he will be paid a severance amount of $37,500 per month for a period of up to six months or until such a time as he finds similar alternative employment, whichever period is shorter. Should Mr.Adent be involuntarily terminated following a change in control of the Registrant within the first two years of his employment, he will be paid his full salary plus benefit continuation for a period of 24 months.

A copy of the press release issued by the Registrant to announce the above is attached to this Current Report as Exhibit 99.1. This press release is being furnished to, as opposed to filed with, the Securities and Exchange Commission.

The feature you requested does not exist. However, we suggest the following feature:

NEOGEN CORPORATION (NASDAQ:NEOG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/17/2017 | 11:15pm CEST

NEOGEN CORPORATION (NASDAQ:NEOG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Item 5.02 Financial Statements and Exhibits.

(d) Exhibits

Exhibit99.1

Press Release issued by the Registrant on July17, 2017

NEOGEN CORP ExhibitEX-99.1 2 d396310dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE   CONTACT: Steven J. Quinlan,…To view the full exhibit click here
About NEOGEN CORPORATION (NASDAQ:NEOG)
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the production and marketing of products dedicated to animal health, including a range of consumable products marketed to veterinarians and animal health product distributors. The Animal Safety segment also provides genetic identification services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides to assist in the control of rodents and disease in and around agricultural, food production and other facilities.

The post NEOGEN CORPORATION (NASDAQ:NEOG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers appeared first on Market Exclusive.

© Market Exclusive 2017, source Market Exclusive

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PATTERSON COMPANIES, INC.
07/17 NEOGEN CORPORATION (NASDAQ : NEOG) Files An 8-K Departure of Directors or Certai..
07/12 PATTERSON COMPANIES, INC. (NASDAQ : PDCO) Files An 8-K Regulation FD Disclosure
07/12 PATTERSON COMPANIES, INC. : Regulation FD Disclosure (form 8-K)
07/12 PATTERSON COMPANIES, INC. : ex-dividend day
06/28 PATTERSON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
06/21 PATTERSON COMPANIES, INC. : Change in Directors or Principal Officers, Regulatio..
06/21 PATTERSON : Announces Animal Health Leadership Transition
06/19 PATTERSON COMPANIES, INC. : Earnings Highlights and Review: Patterson Surpassed ..
06/13 PATTERSON : Declares Regular Quarterly Cash Dividend
06/08 PATTERSON : Foundation awards Leader Dogs for the Blind, a guide dog training or..
More news
News from SeekingAlpha
07/06 Patterson downgraded to Sell at Stifel; shares down 1.35%
06/27 PATTERSON COMPANIES : As Another Top Executive Departs, Shares Continue Rise
06/19 PATTERSON COMPANIES : Seems Destined To Stay Stuck
06/13 Patterson declares $0.26 dividend
06/05 PATTERSON COMPANIES : Will The Company Sell Itself After CEO Abruptly Resigns?
Financials ($)
Sales 2018 5 732 M
EBIT 2018 372 M
Net income 2018 205 M
Debt 2018 978 M
Yield 2018 2,51%
P/E ratio 2018 19,68
P/E ratio 2019 17,86
EV / Sales 2018 0,89x
EV / Sales 2019 0,86x
Capitalization 4 132 M
Chart PATTERSON COMPANIES, INC.
Duration : Period :
Patterson Companies, Inc. Technical Analysis Chart | PDCO | US7033951036 | 4-Traders
Technical analysis trends PATTERSON COMPANIES, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 43,2 $
Spread / Average Target 0,79%
EPS Revisions
Managers
NameTitle
James W. Wiltz President, Chief Executive Officer & Director
John Dean Buck Chairman
Sean M. Muniz Vice President-Operations
Ann B. Gugino Chief Financial Officer, Treasurer & Executive VP
Dave Lardy Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
PATTERSON COMPANIES, INC.4.53%4 132
COLOPLAST A/S13.27%16 713
HENRY SCHEIN21.77%14 655
CANTEL MEDICAL CORP.-4.62%3 216
AMPLIFON SPA32.27%3 151
OWENS & MINOR, INC.-8.73%1 990